Literature DB >> 33938445

Long noncoding RNA MIR4435-2HG enhances metabolic function of myeloid dendritic cells from HIV-1 elite controllers.

Ciputra Adijaya Hartana1, Yelizaveta Rassadkina1, Ce Gao1, Enrique Martin-Gayo2, Bruce D Walker1,3,4, Mathias Lichterfeld1,5,6, Xu G Yu1,5.   

Abstract

Restriction of HIV-1 replication in elite controllers (ECs) is frequently attributed to T cell-mediated immune responses, while the specific contribution of innate immune cells is less clear. Here, we demonstrate an upregulation of the host long noncoding RNA (lncRNA) MIR4435-2HG in primary myeloid dendritic cells (mDCs) from ECs. Elevated expression of this lncRNA in mDCs was associated with a distinct immunometabolic profile, characterized by increased oxidative phosphorylation and glycolysis activities in response to TLR3 stimulation. Using functional assays, we show that MIR4435-2HG directly influenced the metabolic state of mDCs, likely through epigenetic mechanisms involving H3K27ac enrichment at an intronic enhancer in the RPTOR gene locus, the main component of the mammalian target of rapamycin complex 1 (mTORC1). Together, these results suggest a role of MIR4435-2HG for enhancing immunometabolic activities of mDCs in ECs through targeted epigenetic modifications of a member of the mTOR signaling pathway.

Entities:  

Keywords:  AIDS/HIV; Dendritic cells; Immunology; Innate immunity; Noncoding RNAs

Year:  2021        PMID: 33938445      PMCID: PMC8087208          DOI: 10.1172/JCI146136

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  80 in total

Review 1.  Immunometabolic circuits in trained immunity.

Authors:  Rob J W Arts; Leo A B Joosten; Mihai G Netea
Journal:  Semin Immunol       Date:  2016-09-27       Impact factor: 11.130

Review 2.  Dendritic-cell interactions with HIV: infection and viral dissemination.

Authors:  Li Wu; Vineet N KewalRamani
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106

3.  Cellular Metabolism Is a Major Determinant of HIV-1 Reservoir Seeding in CD4+ T Cells and Offers an Opportunity to Tackle Infection.

Authors:  José Carlos Valle-Casuso; Mathieu Angin; Stevenn Volant; Caroline Passaes; Valérie Monceaux; Anastassia Mikhailova; Katia Bourdic; Véronique Avettand-Fenoel; Faroudy Boufassa; Marc Sitbon; Olivier Lambotte; Maria-Isabel Thoulouze; Michaela Müller-Trutwin; Nicolas Chomont; Asier Sáez-Cirión
Journal:  Cell Metab       Date:  2018-12-20       Impact factor: 27.287

4.  Signaling from mTOR to eIF2α mediates cell migration in response to the chemotherapeutic doxorubicin.

Authors:  Robert F Harvey; Tuija A A Pöyry; Mark Stoneley; Anne E Willis
Journal:  Sci Signal       Date:  2019-12-17       Impact factor: 8.192

Review 5.  Trained immunity: A program of innate immune memory in health and disease.

Authors:  Mihai G Netea; Leo A B Joosten; Eicke Latz; Kingston H G Mills; Gioacchino Natoli; Hendrik G Stunnenberg; Luke A J O'Neill; Ramnik J Xavier
Journal:  Science       Date:  2016-04-21       Impact factor: 47.728

Review 6.  CD8+ T cells in HIV control, cure and prevention.

Authors:  David R Collins; Gaurav D Gaiha; Bruce D Walker
Journal:  Nat Rev Immunol       Date:  2020-02-12       Impact factor: 53.106

Review 7.  Long Non-coding RNAs as Functional and Structural Chromatin Modulators in Acute Myeloid Leukemia.

Authors:  Alexander A Wurm; Cristina Pina
Journal:  Front Oncol       Date:  2019-09-11       Impact factor: 6.244

Review 8.  Regulation of Dendritic Cell Immune Function and Metabolism by Cellular Nutrient Sensor Mammalian Target of Rapamycin (mTOR).

Authors:  Julia P Snyder; Eyal Amiel
Journal:  Front Immunol       Date:  2019-01-14       Impact factor: 7.561

Review 9.  Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection.

Authors:  Mihai G Netea; Evangelos J Giamarellos-Bourboulis; Jorge Domínguez-Andrés; Nigel Curtis; Reinout van Crevel; Frank L van de Veerdonk; Marc Bonten
Journal:  Cell       Date:  2020-05-04       Impact factor: 41.582

10.  Immunological Fingerprints of Controllers Developing Neutralizing HIV-1 Antibodies.

Authors:  Enrique Martin-Gayo; Ce Gao; Hsiao Rong Chen; Zhengyu Ouyang; Dhohyung Kim; Kellie E Kolb; Alex K Shalek; Bruce D Walker; Mathias Lichterfeld; Xu G Yu
Journal:  Cell Rep       Date:  2020-01-28       Impact factor: 9.995

View more
  5 in total

Review 1.  Long non-coding RNA MIR4435-2HG: a key molecule in progression of cancer and non-cancerous disorders.

Authors:  Majid Ghasemian; Masoumeh Rajabibazl; Unes Sahebi; Samira Sadeghi; Reza Maleki; Veys Hashemnia; Reza Mirfakhraie
Journal:  Cancer Cell Int       Date:  2022-06-17       Impact factor: 6.429

Review 2.  The Triangle Relationship Between Long Noncoding RNA, RIG-I-like Receptor Signaling Pathway, and Glycolysis.

Authors:  Zhihua Ren; Yueru Yu; Chaoxi Chen; Dingyong Yang; Ting Ding; Ling Zhu; Junliang Deng; Zhiwen Xu
Journal:  Front Microbiol       Date:  2021-11-30       Impact factor: 5.640

Review 3.  Effective innate immune response in natural HIV-1 controllers. Can mimicking lead to novel preventive and cure strategies against HIV-1?

Authors:  Marta Calvet-Mirabent; Enrique Martín-Gayo
Journal:  Curr Opin HIV AIDS       Date:  2022-07-25       Impact factor: 4.061

4.  Immune correlates of HIV-1 reservoir cell decline in early-treated infants.

Authors:  Ciputra Adijaya Hartana; Pilar Garcia-Broncano; Yelizaveta Rassadkina; Xiaodong Lian; Chenyang Jiang; Kevin B Einkauf; Kenneth Maswabi; Gbolahan Ajibola; Sikhulile Moyo; Terence Mohammed; Comfort Maphorisa; Joseph Makhema; Yuko Yuki; Maureen Martin; Kara Bennett; Patrick Jean-Philippe; Mathias Viard; Michael D Hughes; Kathleen M Powis; Mary Carrington; Shahin Lockman; Ce Gao; Xu G Yu; Daniel R Kuritzkes; Roger Shapiro; Mathias Lichterfeld
Journal:  Cell Rep       Date:  2022-07-19       Impact factor: 9.995

Review 5.  Immunological effector mechanisms in HIV-1 elite controllers.

Authors:  Ciputra Adijaya Hartana; Xu G Yu
Journal:  Curr Opin HIV AIDS       Date:  2021-09-01       Impact factor: 4.061

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.